Clinical trial
Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate…
NCT00307684 · Janssen-Cilag International NV, Industry · Completed
Key facts
| NCT number | NCT00307684 |
|---|---|
| Title | Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
| Official title | An Open International Multicentre Long-Term Follow Up Study to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder |
| Lead sponsor | Janssen-Cilag International NV, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug |
| Interventions | double blind placebo, double blind PR OROS methylphenidate, open label PR OROS methylphenidate |
| Enrollment | 155 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Mar 28, 2006 |
| Last update posted | Apr 21, 2014 |
| Countries | France, Germany, Netherlands, Norway, Portugal, Spain, Switzerland |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: